Protective activation of the endocannabinoid system during ischemia in dopamine neurons

被引:89
作者
Melis, Miriam [1 ]
Pillolla, Giuliano
Bisogno, Tiziana
Minassi, Alberto
Petrosino, Stefania
Perra, Simona
Muntoni, Anna Lisa
Lutz, Beat
Gessa, Gian Luigi
Marsicano, Giovanni
Di Marzo, Vincenzo
Pistis, Marco
机构
[1] Univ Cagliari, Bb Brodie Dept Neurosci, CNR, Inst Neurosci, I-09042 Monserrato, Italy
[2] Univ Cagliari, Ctr Excellence Neurobiol & Addict, Cagliari, Italy
[3] CNR, Endocannabinoid Res Grp, Inst Biomol Chem, Pozzuoli, Italy
[4] Johannes Gutenberg Univ Mainz, Dept Physiol Chem, D-6500 Mainz, Germany
关键词
CB1; dopamine; endocannabinoid; ischemia; midbrain; neuroprotection; retrograde signal;
D O I
10.1016/j.nbd.2006.04.010
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Endocannabinoids act as neuroprotective molecules promptly released in response to pathological stimuli. Hence, they may represent one component of protection and/or repair mechanisms mobilized by dopamine (DA) neurons under ischemia. Here, we show that the endocannabinoid 2-arachidonoyl-glycerol (2-AG) plays a key role in protecting DA neurons from ischemia-induced altered spontaneous activity both in vitro and in vivo. Accordingly, neuroprotection can be elicited through moderate cannabinoid receptor type-1 (CB1) activation. Conversely, blockade of endocannabinoid actions through CB1 receptor antagonism worsens the outcome of transient ischemia on DA neuronal activity. These findings indicate that 2-AG mediates neuroprotective actions by delaying damage and/or restoring function of DA cells through activation of presynaptic CB1 receptors. Lastly, they point to CB1 receptors as valuable targets in protection of DA neurons against ischemic injury and emphasize the need for a better understanding of endocannabinoid actions in the fine control of DA transmission. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:15 / 27
页数:13
相关论文
共 98 条
[51]   On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures [J].
Lutz, B .
BIOCHEMICAL PHARMACOLOGY, 2004, 68 (09) :1691-1698
[52]   Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus [J].
Makara, JK ;
Mor, M ;
Fegley, D ;
Szabó, SI ;
Kathuria, S ;
Astarita, G ;
Duranti, A ;
Tontini, A ;
Tarzia, G ;
Rivara, S ;
Freund, TF ;
Piomelli, D .
NATURE NEUROSCIENCE, 2005, 8 (09) :1139-1141
[53]  
Marinelli S, 2003, J NEUROSCI, V23, P3136
[54]   Hypoglycemia enhances ionotropic but reduces metabotropic glutamate responses in substantia nigra dopaminergic neurons [J].
Marinelli, S ;
Federici, M ;
Giacomini, P ;
Bernardi, G ;
Mercuri, NB .
JOURNAL OF NEUROPHYSIOLOGY, 2001, 85 (03) :1159-1166
[55]   Pharmacological identification of the K+ currents mediating the hypoglycemic hyperpolarization of rat midbrain dopaminergic neurones [J].
Marinelli, S ;
Bernardi, G ;
Giacomini, P ;
Mercuri, NB .
NEUROPHARMACOLOGY, 2000, 39 (06) :1021-1028
[56]  
MARINELLI S, 2004, 2004 S CANN BURL VER, P140
[57]   CB1 cannabinoid receptors and on-demand defense against excitotoxicity [J].
Marsicano, G ;
Goodenough, S ;
Monory, K ;
Hermann, H ;
Eder, M ;
Cannich, A ;
Azad, SC ;
Cascio, MG ;
Gutiérrez, SO ;
van der Stelt, M ;
López-Rodríguez, ML ;
Casanova, E ;
Schütz, G ;
Zieglgänsberger, W ;
Di Marzo, V ;
Behl, C ;
Lutz, B .
SCIENCE, 2003, 302 (5642) :84-88
[58]   IDENTIFICATION OF AN ENDOGENOUS 2-MONOGLYCERIDE, PRESENT IN CANINE GUT, THAT BINDS TO CANNABINOID RECEPTORS [J].
MECHOULAM, R ;
BENSHABAT, S ;
HANUS, L ;
LIGUMSKY, M ;
KAMINSKI, NE ;
SCHATZ, AR ;
GOPHER, A ;
ALMOG, S ;
MARTIN, BR ;
COMPTON, DR ;
PERTWEE, RG ;
GRIFFIN, G ;
BAYEWITCH, M ;
BARG, J ;
VOGEL, Z .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (01) :83-90
[59]   Stout guards of the central nervous system [J].
Mechoulam, R ;
Lichtman, AH .
SCIENCE, 2003, 302 (5642) :65-+
[60]  
MECHOULAM R, 2002, SCI STKE, V129